Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,956 | 3,615 | 5,728 | 5,840 | 8,314 |
| Marketable Securities | 250 | 273 | N/A | 0 | N/A |
| Receivables | 4,234 | 4,015 | 3,977 | 3,286 | 3,205 |
| TOTAL | $7,440 | $7,903 | $9,705 | $9,126 | $11,519 |
| Non-Current Assets | |||||
| PPE Net | 44 | 47 | 41 | 24 | 24 |
| Investments And Advances | 0 | 0 | 1,077 | 1,829 | 927 |
| Other Non-Current Assets | 5 | 2 | 2 | 5 | 5 |
| TOTAL | $49 | $49 | $1,120 | $1,858 | $956 |
| Total Assets | $7,489 | $7,952 | $10,825 | $10,984 | $12,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,705 | 2,193 | 1,504 | 1,365 | 1,817 |
| TOTAL | $2,705 | $3,119 | $2,361 | $2,157 | $2,547 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,000 | 926 | 857 | 792 | 730 |
| TOTAL | $1,539 | $1,818 | $2,077 | $2,317 | $2,499 |
| Total Liabilities | $4,244 | $4,937 | $4,438 | $4,474 | $5,046 |
| Shareholders' Equity | |||||
| Common Shares | 2,939 | 2,635 | 2,633 | 2,633 | 2,605 |
| Retained earnings | -102,455 | -100,623 | -97,194 | -97,017 | -94,646 |
| Other shareholders' equity | 7,000 | 6,927 | 19,302 | 19,248 | 18,054 |
| TOTAL | $3,245 | $3,015 | $6,387 | $6,510 | $7,429 |
| Total Liabilities And Equity | $7,489 | $7,952 | $10,825 | $10,984 | $12,475 |